200 related articles for article (PubMed ID: 31530048)
1. Lower socioeconomic status is associated with an increased prevalence of comorbid anxiety and depression among patients with irritable bowel syndrome: results from a multicenter cohort.
Silvernale C; Kuo B; Staller K
Scand J Gastroenterol; 2019 Sep; 54(9):1070-1074. PubMed ID: 31530048
[No Abstract] [Full Text] [Related]
2. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.
Lee S; Wu J; Ma YL; Tsang A; Guo WJ; Sung J
Aliment Pharmacol Ther; 2009 Sep; 30(6):643-51. PubMed ID: 19552631
[TBL] [Abstract][Full Text] [Related]
3. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.
Lee YT; Hu LY; Shen CC; Huang MW; Tsai SJ; Yang AC; Hu CK; Perng CL; Huang YS; Hung JH
PLoS One; 2015; 10(7):e0133283. PubMed ID: 26222511
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.
Dold M; Bartova L; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
J Psychiatr Res; 2017 Aug; 91():1-13. PubMed ID: 28284107
[TBL] [Abstract][Full Text] [Related]
5. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years.
Moffitt TE; Harrington H; Caspi A; Kim-Cohen J; Goldberg D; Gregory AM; Poulton R
Arch Gen Psychiatry; 2007 Jun; 64(6):651-60. PubMed ID: 17548747
[TBL] [Abstract][Full Text] [Related]
6. Gender-specific prevalence and associated factors of major depressive disorder and generalized anxiety disorder in a Chinese rural population: the Henan rural cohort study.
Luo Z; Li Y; Hou Y; Liu X; Jiang J; Wang Y; Liu X; Qiao D; Dong X; Li R; Wang F; Wang C
BMC Public Health; 2019 Dec; 19(1):1744. PubMed ID: 31881870
[TBL] [Abstract][Full Text] [Related]
7. Risk of psychiatric disorders in irritable bowel syndrome-A nationwide, population-based, cohort study.
Yeh HW; Chien WC; Chung CH; Hu JM; Tzeng NS
Int J Clin Pract; 2018 Jul; 72(7):e13212. PubMed ID: 29920876
[TBL] [Abstract][Full Text] [Related]
8. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression.
Gros DF; Antony MM; McCabe RE; Swinson RP
J Anxiety Disord; 2009 Mar; 23(2):290-6. PubMed ID: 18819774
[TBL] [Abstract][Full Text] [Related]
9. An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder.
Kaplan A; Franzen MD; Nickell PV; Ransom D; Lebovitz PJ
Int J Psychiatry Clin Pract; 2014 Jan; 18(1):11-5. PubMed ID: 23980534
[TBL] [Abstract][Full Text] [Related]
10. Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies.
Geng Q; Zhang QE; Wang F; Zheng W; Ng CH; Ungvari GS; Wang G; Xiang YT
J Affect Disord; 2018 Sep; 237():37-46. PubMed ID: 29758449
[TBL] [Abstract][Full Text] [Related]
11. Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey--Mental Health (CCHS-MH).
Deschênes SS; Burns RJ; Schmitz N
J Psychosom Res; 2015 Feb; 78(2):137-42. PubMed ID: 25510185
[TBL] [Abstract][Full Text] [Related]
12. Irritable bowel syndrome: a co-twin control analysis.
Wojczynski MK; North KE; Pedersen NL; Sullivan PF
Am J Gastroenterol; 2007 Oct; 102(10):2220-9. PubMed ID: 17897337
[TBL] [Abstract][Full Text] [Related]
13. The effect of anxiety and depression on the risk of irritable bowel syndrome in migraine patients.
Wu MF; Yang YW; Chen YY
J Clin Neurosci; 2017 Oct; 44():342-345. PubMed ID: 28694040
[TBL] [Abstract][Full Text] [Related]
14. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
15. Comorbid anxiety disorders in late-life depression: results of a cohort study.
van der Veen DC; van Zelst WH; Schoevers RA; Comijs HC; Voshaar RC
Int Psychogeriatr; 2015 Jul; 27(7):1157-65. PubMed ID: 25370017
[TBL] [Abstract][Full Text] [Related]
16. Mood and Anxiety Disorders in Chronic Fatigue Syndrome, Fibromyalgia, and Irritable Bowel Syndrome: Results From the LifeLines Cohort Study.
Janssens KA; Zijlema WL; Joustra ML; Rosmalen JG
Psychosom Med; 2015 May; 77(4):449-57. PubMed ID: 25768845
[TBL] [Abstract][Full Text] [Related]
17. Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease.
Kovács Z; Kovács F
Int J Psychiatry Med; 2007; 37(3):245-55. PubMed ID: 18314852
[TBL] [Abstract][Full Text] [Related]
18. Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan, Iran.
Modabbernia MJ; Mansour-Ghanaei F; Imani A; Mirsafa-Moghaddam SA; Sedigh-Rahimabadi M; Yousefi-Mashhour M; Joukar F; Atrkar-Roushan Z; Bidel S
BMC Res Notes; 2012 Feb; 5():112. PubMed ID: 22353390
[TBL] [Abstract][Full Text] [Related]
19. Generalized anxiety and major depressive disorders, their comorbidity and hypertension in middle-aged men.
Carroll D; Phillips AC; Gale CR; Batty GD
Psychosom Med; 2010 Jan; 72(1):16-9. PubMed ID: 19933507
[TBL] [Abstract][Full Text] [Related]
20. [The prevalence of generalized anxiety disorder and comorbidity among psychiatric outpatients].
Ozcan M; Uğuz F; Cilli AS
Turk Psikiyatri Derg; 2006; 17(4):276-85. PubMed ID: 17183444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]